Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)
Status:
Completed
Trial end date:
2017-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Riluzole is effective in the augmentation
treatment of post-traumatic stress disorder (PTSD) that is experienced by Active Duty
military service members and Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF),
and Operation New Dawn (OND) veterans who have not had symptom reduction after one or more
kinds of medications or therapies.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Uniformed Services University of the Health Sciences
Collaborators:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command